Fig. 1: Preliminary evaluation of specific modification of Endo-F3(D165A)-CPD mediated by InsP6.

LC-MS analysis of Endo-F3(D165A)-CPD after incubation with InsP6 (a), with 3-azidopropylamine (b), with InsP6 and 3-azidopropylamine (c) or incubation with InsP6 for 2 h and then 3-azidopropylamine was added (d).